Analysis on the Use of Diabetes Essential Drugs in Dongguan from 2020 to 2022
OBJECTIVE To analyze the use of diabetes essential drugs after the national essential drug system was promoted in Dongguan City from 2020 to 2022.METHODS Using drug frequency analysis as the method,the drug frequency(DDDs),limited daily cost(DDC)and ranking ratio as the indexes to analyze the situation of diabetes drug use since the national essential drug system was promoted in Dongguan.RESULTS The purchase amount and DDDs of essential drugs for treating diabetes were larger than those of non-essential drugs,and the DDC value of essential drugs was smaller than that of non-essential drugs.From 2020 to 2022,the proportion of funds for the purchase of essential drugs for the treatment of diabetes was 66.00％,63.65％,67.48％.DDDs accounted for 72.03％,74.18％,73.51％.DDCS were 2.78,2.19,and 2.11 respectively.The growth rate of DDDS of essential medicines for treating diabetes in 2021 and 2022 was 5.88％and 12.24％respectively,showing an upward trend,of which the growth rate in 2022 was 18.84％compared with 2020.The overall growth of DDDs of essential drugs was higher than that of non-essential drugs.Both the DDC of essential drugs and the DDC of non-essential drugs for the treatment of diabetes showed a decreasing trend in the past three years.CONCLUSION After the promotion of the national essential medicine system in Dongguan city,essential drugs dominate the diabetes treatment drugs from 2020 to 2022,and the use of essential drugs shows an increasing trend,which effectively reduces the economic burden of diabetes patients in Dongguan.
diabetesessential drugsmedication frequency(DDDs)limited daily fee(DDC)ranking ratio
万方数据
维普
